The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global enteric softgel capsules market reached a value of US$ 2,379 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 3,067 Million by 2027, exhibiting a CAGR of 4.23% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Enteric softgel capsules are extended-release tablets with an acid-resistant coating to prevent them from dissolving in the stomach during digestion. They are enclosed in gelatin-based shell coating that delays the release, enhances tolerance, and minimizes poor aftertaste. They help prevent gastric irritation and reflux, protect the active pharmaceutical ingredients (API), and inhibit gastric irritation and reflux. They exhibit preserved enzyme activity and enhanced bioavailability, absorption, and efficacy. As a result, they are extensively used in formulating multivitamin supplements to treat vitamin and nutrient deficiency caused by improper diet, pregnancy, or illness.
The growing global geriatric population, along with the rising prevalence of chronic medical disorders and nutrient-deficient diseases, represents one of the key factors positively influencing the market. In addition, the rising health awareness among individuals and the growing acceptance of nutritional and dietary supplements are catalyzing the demand for enteric softgel capsules across the globe. Besides this, significant growth in the pharmaceutical industry and the expanding applications of the product to enclose omega-3 oils and other gel-based supplements are offering a favorable market outlook. Additionally, product innovations like the introduction of non-gelatin-based enteric softgel capsules are strengthening the growth of the market. In addition, leading players are focusing on manufacturing novel variants by using starch and other organic, plant-based sources to meet the requirements of vegan consumers. Furthermore, the growing expansion of pharmacies and the proliferation of online pharmacies through e-commerce retail channels are creating a positive outlook for the market. Moreover, increasing investments by leading pharma companies in research and development (R&D) activities to improve the bioavailability of these capsules are expected to propel market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global enteric softgel capsules market report, along with forecasts for growth at the global and regional levels from 2022-2027. Our report has categorized the market based on type, application, and distribution channel.
Breakup by Type:
Gelatin capsules currently represent the largest market segment due to the increasing vegan population across the globe.
Breakup by Application:
Health supplements hold the majority of the global enteric softgel capsules market share due to the increasing usage of softgel capsules by fitness enthusiasts and rising awareness among individuals about nutraceutical supplements.
Breakup by Distribution Channel:
Pharmacy and drug stores presently dominate the market on account of the increasing consumer preference to purchase medicinal products from registered pharmacies or drug stores.
Breakup by Region:
North America exhibits a clear dominance in the market as healthcare providers are increasingly investing in research and development (R&D) activities to introduce effective treatment alternatives.
The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Some of these players are Aenova Group GmbH, BASF SE, Catalent, Inc., Colorcon Inc., Fuji Capsule Co., Ltd., Lonza Group AG, Now Health Group, Inc., ProCaps Group, Super Spectrim and Thermo Fisher Scientific, Inc.
|Base Year of the Analysis||2021|
|Segment Coverage||Type, Application, Distribution Channel, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Aenova Group, BASF SE, Catalent Inc, Colorcon Inc., Fuji Capsule Co. Ltd., Lonza Group AG, NOW Foods, ProCaps, Super Spectrim and Thermo Fisher Scientific Inc.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Key Questions Answered in This Report:
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at